123 related articles for article (PubMed ID: 12684096)
1. Conformational and biological studies for a pair of novel synthetic AT1 antagonists: stereoelectronic requirements for antihypertensive efficacy.
Zoumpoulakis P; Zoga A; Roumelioti P; Giatas N; Grdadolnik SG; Iliodromitis E; Vlahakos D; Kremastinos D; Matsoukas JM; Mavromoustakos T
J Pharm Biomed Anal; 2003 Apr; 31(5):833-44. PubMed ID: 12684096
[TBL] [Abstract][Full Text] [Related]
2. Structure elucidation and conformational study of V8: a novel synthetic non peptide AT(1) antagonist.
Zoumpoulakis P; Politi A; Grdadolnik SG; Matsoukas J; Mavromoustakos T
J Pharm Biomed Anal; 2006 Mar; 40(5):1097-104. PubMed ID: 16260110
[TBL] [Abstract][Full Text] [Related]
3. Conformation and bioactivity. Design and discovery of novel antihypertensive drugs.
Mavromoustakos T; Zervou M; Zoumpoulakis P; Kyrikou I; Benetis NP; Polevaya L; Roumelioti P; Giatas N; Zoga A; Minakakis PM; Kolocouris A; Vlahakos D; Grdadolnik SG; Matsoukas J
Curr Top Med Chem; 2004; 4(4):385-401. PubMed ID: 14965308
[TBL] [Abstract][Full Text] [Related]
4. Structure elucidation and conformational properties of eprosartan, a non peptide angiotensin II AT1 antagonist.
Zoumpoulakis P; Grdadolnik SG; Matsoukas J; Mavromoustakos T
J Pharm Biomed Anal; 2002 Apr; 28(1):125-35. PubMed ID: 11861115
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel antihypertensive drugs.
Moutevelis-Minakakis P; Gianni M; Stougiannou H; Zoumpoulakis P; Zoga A; Vlahakos AD; Iliodromitis E; Mavromoustakos T
Bioorg Med Chem Lett; 2003 May; 13(10):1737-40. PubMed ID: 12729654
[TBL] [Abstract][Full Text] [Related]
6. Efforts to understand the molecular basis of hypertension through drug:membrane interactions.
Mavromoustakos T; Zoumpoulakis P; Kyrikou I; Zoga A; Siapi E; Zervou M; Daliani I; Dimitriou D; Pitsas A; Kamoutsis C; Laggner P
Curr Top Med Chem; 2004; 4(4):445-59. PubMed ID: 14965311
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of benzyl benzoate and its derivatives on angiotensin II-induced hypertension.
Ohno O; Ye M; Koyama T; Yazawa K; Mura E; Matsumoto H; Ichino T; Yamada K; Nakamura K; Ohno T; Yamaguchi K; Ishida J; Fukamizu A; Uemura D
Bioorg Med Chem; 2008 Aug; 16(16):7843-52. PubMed ID: 18672373
[TBL] [Abstract][Full Text] [Related]
8. An effort to understand the molecular basis of hypertension through the study of conformational analysis of losartan and sarmesin using a combination of nuclear magnetic resonance spectroscopy and theoretical calculations.
Mavromoustakos T; Kolocouris A; Zervou M; Roumelioti P; Matsoukas J; Weisemann R
J Med Chem; 1999 May; 42(10):1714-22. PubMed ID: 10346924
[TBL] [Abstract][Full Text] [Related]
9. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat.
Therrien F; Lemieux P; Bélanger S; Agharazii M; Lebel M; Larivière R
Eur J Pharmacol; 2009 Apr; 607(1-3):126-34. PubMed ID: 19326569
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog.
Lee BH; Lee SH; Jung YS; Seo HW; Yoo SE; Shin HS
J Pharm Pharmacol; 1999 Oct; 51(10):1191-200. PubMed ID: 10579691
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, binding studies and in vivo biological evaluation of novel non-peptide antihypertensive analogues.
Mavromoustakos T; Moutevelis-Minakakis P; Kokotos CG; Kontogianni P; Politi A; Zoumpoulakis P; Findlay J; Cox A; Balmforth A; Zoga A; Iliodromitis E
Bioorg Med Chem; 2006 Jul; 14(13):4353-60. PubMed ID: 16546395
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.
Mazzolai L; Maillard M; Rossat J; Nussberger J; Brunner HR; Burnier M
Hypertension; 1999 Mar; 33(3):850-5. PubMed ID: 10082498
[TBL] [Abstract][Full Text] [Related]
14. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.
Naik P; Murumkar P; Giridhar R; Yadav MR
Bioorg Med Chem; 2010 Dec; 18(24):8418-56. PubMed ID: 21071232
[TBL] [Abstract][Full Text] [Related]
16. Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist.
Wu J; Wang Q; Guo J; Hu Z; Yin Z; Xu J; Wu X
Eur J Pharmacol; 2008 Jul; 589(1-3):220-4. PubMed ID: 18571160
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive drugs that act on Renin-Angiotensin System with emphasis in AT(1) antagonists.
Mavromoustakos T; Apostolopoulos V; Matsoukas J
Mini Rev Med Chem; 2001 Jul; 1(2):207-17. PubMed ID: 12369985
[TBL] [Abstract][Full Text] [Related]
18. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.
Culman J; von Heyer C; Piepenburg B; Rascher W; Unger T
Eur J Pharmacol; 1999 Feb; 367(2-3):255-65. PubMed ID: 10079000
[TBL] [Abstract][Full Text] [Related]
19. Transdermal Delivery of AT1 Receptor Antagonists Reduce Blood Pressure and Reveal a Vasodilatory Effect on Kidney Blood Vessels.
Michalatou M; Androutsou ME; Antonopoulos M; Vlahakos DV; Agelis G; Zulli A; Qaradakhi T; Mikkelsen K; Apostolopoulos V; Matsoukas J
Curr Mol Pharmacol; 2018; 11(3):226-236. PubMed ID: 29676239
[TBL] [Abstract][Full Text] [Related]
20. [Antihypertensive advantages of angiotensin II AT1 receptor antagonism].
Coca A; Giner V
Rev Esp Cardiol; 1999; 52 Suppl 3():53-8. PubMed ID: 10614150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
